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Abstract: Reactive oxygen species (ROS), a by-product of aerobic life, are highly reactive molecules
with unpaired electrons. The excess of ROS leads to oxidative stress, instigating the peroxidation
of polyunsaturated fatty acids (PUFA) in the lipid membrane through a free radical chain reaction
and the formation of the most bioactive aldehyde, known as 4-hydroxynonenal (4-HNE). 4-HNE
functions as a signaling molecule and toxic product and acts mainly by forming covalent adducts with
nucleophilic functional groups in proteins, nucleic acids, and lipids. The mitochondria have been
implicated as a site for 4-HNE generation and adduction. Several studies clarified how 4-HNE affects
the mitochondria’s functions, including bioenergetics, calcium homeostasis, and mitochondrial dynamics. Our research group has shown that 4-HNE activates mitochondria apoptosis-inducing factor
(AIFM2) translocation and facilitates apoptosis in mice and human heart tissue during anti-cancer
treatment. Recently, we demonstrated that a deficiency of SOD2 in the conditional-specific cardiac
knockout mouse increases ROS, and subsequent production of 4-HNE inside mitochondria leads to
the adduction of several mitochondrial respiratory chain complex proteins. Moreover, we highlighted
the physiological functions of HNE and discussed their relevance in human pathophysiology and
current discoveries concerning 4-HNE effects on mitochondria.
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1. Introduction
Reactive oxygen species (ROS) such as superoxide, hydrogen peroxide, hydroxyl
radical, singlet oxygen, and lipid peroxyl radicals are natural by-products of cellular respiration, prostaglandin synthesis, and the cytochrome P450 system [1–3]. However, when the
levels of these oxidants surpass endogenous levels, it leads to oxidative stress, producing
cytotoxic effects and cell death [2]. Increased levels of ROS are seen in many diseases, as
well as in severe tissue damage [4]. These include, but are not limited to, traumatic brain
injury [5], Alzheimer’s disease, diabetes, aging [2], infertility [6], doxorubicin-induced
cardiac injury [7], and cardiac ischemia-reperfusion injury [8]. Data from certain disease
models have implied that mitochondrial production of superoxide radicals (O2 − ) is a
major instigator of oxidative stress [9–12]. This oxidative stress leads to peroxidation in
the lipid membrane and subsequent reactive aldehyde formation such as the formation of
4-HNE [2,6] (Figure 1). This highly reactive and cytotoxic aldehyde is then able to form
covalent adducts with proteins, nucleic acids, and other lipids [2]. Adduction of 4-HNE to
DNA leads to DNA damage, fragmentation, and subsequent cell death [7]. 4-HNE adducts
with the protein via Schiff’s base formation and Michael addition by reacting with the
aldehyde group and double bond in 4-HNE, respectively. These 4-HNE–protein adducts
can lead to protein inactivation, aggregation, and change in protein conformation and
function [13].
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cium homeostasis, and regulation of cell death [15]. Mitochondria are double-membrane
organelles with an ample number of lipids. Although most of the lipids are synthesized
organelles with an ample number of lipids. Although most of the lipids are synthesized
in the endoplasmic reticulum, de novo lipid synthesis and remodeling of mitochondrial
in the endoplasmic reticulum, de novo lipid synthesis and remodeling of mitochondrial
lipids have been shown to play a significant role in maintaining the structural integrity and
lipids have been shown to play a significant role in maintaining the structural integrity
function of the mitochondria [16]. The most copious phospholipids in the mitochondrial
and function of the mitochondria [16]. The most copious phospholipids in the mitochonmembrane are phosphatidylcholine (PC) and phosphatidylethanolamine (PE), comprising
drial membrane are phosphatidylcholine (PC) and phosphatidylethanolamine (PE), comabout 40–55% and 30–45% of total mitochondrial phospholipids, respectively. Cardiolipin
(CL) accounts for 10–15% of mitochondrial phospholipids. Other common lipids found
in the mitochondria in modest numbers are phosphatidylserine (PS), sphingolipids, and
sterols [17,18]. A significant role of CL includes the organization of cristae, execution
of apoptosis, mitochondrial respiration, mitochondrial dynamics via fission and fusion,
carrier protein activity, and signaling during apoptosis [19]. Mitochondria act as a critical
source and target of reactive oxygen species [20]. The major source of ROS inside the
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mitochondria is the respiratory chain complex under physiological and pathological conditions [21]. Due to the high content of unsaturated fatty acid and its location near the site of
generation of ROS, CL is highly prone to lipid peroxidation [22]. Cardiolipin peroxidation
is linked to several pathological conditions such as ischemia-reperfusion, non-alcoholic
fatty liver, hyperthyroidism, traumatic brain injury, and atherosclerosis [23–27]. Recently, it
has been shown that the bioactive lipid 4-HNE is also derived from the peroxidation of a
mitochondrial-specific phospholipid, CL [27–29]. The mechanism of formation of 4-HNE
from cardiolipin includes cross-chain peroxyl radical addition and decomposition [29].
3. Metabolism of 4-HNE
The metabolism of 4-HNE depends on the location, cell type, and concentration of
4-HNE present on a particular site. Aldehyde dehydrogenases (ALDH), aldose reductase
(AR), and glutathione S-transferases (GST) are the major enzymes that metabolize and
control 4-HNE levels in cells [30–32]. Aldehyde dehydrogenases are major enzymes that
play a significant role in the metabolism of 4-HNE and other xenogeneic and biogenic
aldehydes [33,34]. 4-HNE is oxidized into a non-toxic 4-hydroxy-2-nonenoic acid by ALDH.
Multiple ALDH isozymes in different organs contribute to cytoprotection against 4-HNE
and other reactive-aldehyde-induced injuries. ALDH2 is primarily present in mitochondria
and is involved in the metabolism of 4-HNE in the heart under disease conditions. It has
been shown that 4-HNE inactivates ALDH, and its levels decreased in some pathological
hearts [34,35]. The overexpression of ALDH has been found to be protective against 4HNE, whereas its deletion causes various cardiovascular consequences. The presence
of ALDH is significantly beneficial against 4-HNE in metabolic diseases such as cancer
and diabetes [36–38]. The primary therapeutics targeting 4-HNE are antioxidants such as
N-acetylcysteine and α-lipoic acid, which enhance ALDH activity and expression [39,40]. It
was found that ALDH2 activation can transform deleterious 4-HNE-mediated autophagy
into a beneficial state; this effect is mediated by the upregulation of phosphoryl AMPK and
Akt during various cardiovascular diseases. The expression and activity of ALDH2 are
considered promising therapeutic strategies for reducing the effect of 4-HNE on multiple
diseases [41]. In recent days, there has been an attempt to use Alda-1, a molecular-weight
activator of ALDH2, which has been shown to attenuate 4-HNE adduction in various
pathological conditions such as stroke, hyperoxia-induced lung injury, hypoxia-induced
pulmonary hypertension, hepatic ischemia-reperfusion injury, and atherosclerosis [42–46].
Various chains of saturated and unsaturated aldehydes are catalyzed by aldose reductase and metabolize aldehyde–glutathione conjugates such as glutathione S–HNE. AR
inhibition leads to 4-HNE accumulation in the heart and blood vessels. It has been reported
that 4-HNE can be efficiently detoxified by the aldo-keto reductase aldose reductase, which
is purified from the bovine lens [47,48]. A new, efficient detoxification route of HNE is
through the enzymatic reaction of aldose reductase, where the natural substrate HNE and
HNE-GS are reduced [49]. GST is the most critical determinant of cellular 4-HNE, which
detoxifies 4-HNE in most cells. 4-HNE is metabolized when it binds with the GSH, thereby
forming a glutathione S conjugate of 4-HNE (GS–HNE) and reducing its toxicity to the
cells [50,51]. GSH and GST both play a significant role in the detoxification and protection
of cells from 4-HNE-mediated cell injury and damage [50].
4. Mitochondrial Dysfunction Mediated by 4-HNE
4.1. Exogenous 4-HNE and Mitochondrial Dysfunction
As was mentioned previously, 4-HNE can target protein for its adduction. The mitochondrial protein comprises thirty percent of all the proteins modified by 4-HNE [3].
Both exogenously given and endogenously produced 4-HNE due to oxidative stress have
been shown to cause mitochondrial dysfunction in various cell types and organs during
physiological and pathological conditions. Small airway epithelial cells (SAECs) form
a continuous lining around alveoli and provide a barrier and immunological protection
to the lung. These cells are susceptible to damage by oxidative stress, therefore, need to
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be protected in order to maintain the epithelial membrane barrier to the airway [52–54].
A previous study performed in a hyperoxic acute lung injury mice model showed that
HNE–protein adducts increase in the lung after exposure to hyperoxia. When human small
airway epithelial cells (SAECs) were treated with 25 µM of 4-HNE, it caused a significant
decrease in oxygen consumption rate, ATP production, membrane potential, and activity of
aconitase [55]. Although they showed that 4-HNE leads to impairment of the mitochondrial
energy generation process and a decrease in SAECs survival, they did not perform any
study to show the direct modification of any mitochondrial respiratory chain proteins by 4HNE. Previous studies demonstrated that alternation in mitochondrial dynamic processes,
such as fission and fusion, leads to neuronal dysfunction [56,57]. A study performed on
primary neurons showed decreased mitochondrial length when they were treated with a
15 µM concentration of 4-HNE. 4-HNE also caused a decrease in complex I and complex
V activity, mostly at the 15 µM concentration. 4-HNE treatment also had an effect on
mitochondrial fission and fusion proteins. 4-HNE treatment decreased the mitochondrial
fusion proteins, such as OPA1 and MFN2, whereas it increased the protein level of fission
proteins p-DNM1L and DNM1L, which might have led to a decrease in mitochondrial
length [58]. When PC12 cells were treated with 4-HNE, there was a 70% decrease in cytochrome C oxidase activity and a reduction in the activity of mitochondrial matrix enzyme
aconitase [59]. Mitochondrial bioenergetic efficiency changes with the level of skeletal
muscle activity. When the impact of lipid peroxidation was tested on C2C12 myotubes by
directly treating them with 4-HNE, it decreased ATP production, mitochondrial respiration,
and spare respiratory capacity. Treatment with 4-HNE also showed an increment in NADH
inside the mitochondria indicative of a reduction in complex I activity [60]. However, the
direct role of 4-HNE was not examined using a mice model of skeletal muscle injury in
this study. Mitochondria are a major source of ROS production; therefore, mitochondrial
proteins are highly susceptible to oxidative modification [61]. Previously, the presence of
4-HNE-modified mitochondrial respiratory chain complexes (I–V) was reported in adult
bovine heart submitochondrial particles (SMP). When 4-HNE was added to the brain
mitochondria, it was shown to significantly increase 4-HNE-bound proteins and decrease
mitochondrial complex-I- and complex-II-mediated respiration [62].
4.2. Role of 4-HNE Causing Mitochondrial Dysfunction in Various Diseases
Cardiac remodeling after myocardial infarction may lead to heart failure. Oxidative
stress is one of the mechanisms by which cardiac remodeling occurs after myocardial
infarction [63]. A study performed by Katia et al. in post-cardiac remodeling showed
that 4-HNE adducted protein augmented during myocardial ischemia cardiomyopathy
progression [64]. The voltage-dependent anion channel (VDAC) and mitochondrial calcium uniporter (MCU) are Ca2+ transport channels located in the outer membrane of
mitochondria (OMM) and inner membrane of the mitochondrion (IMM), respectively [65].
A study by Saten et al. recently demonstrated that MAO-A augmentation after myocardial
ischemia is a source of H2 O2 , leading to the generation of reactive aldehyde inside the
mitochondria. 4-HNE produced inside the mitochondria is produced via peroxidation
of cardiolipin. In the case of post-ischemic cardiac remodeling, CL-peroxidation-derived
4-HNE adducts with the VDAC and MCU lead to the accumulation of calcium inside the
mitochondria of cardiomyocytes (Table 1) [66]. This results in increased scar formation
and reduced systolic function, as shown by the ejection fraction and fractional shortening.
When they used the MAO-A inhibitor moclobemide, they reduced the 4-HNE adduct and
improved cardiac function [66]. In patients with congenital heart disease, 4-HNE modified
mitochondrial proteins related to metabolisms such as NADH dehydrogenase [ubiquinone]
iron–sulfur protein 3, NADH dehydrogenase [ubiquinone] iron–sulfur protein 2, elongation factor Tu, dihydrolipoyl dehydrogenase, ES1 protein homolog, fumarate hydratase,
creatine kinase S-type, cytochrome b–c1 complex subunit 1, aconitate hydratase, NADH
dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10 cytochrome c1, heme proteins
such as myoglobin, and cytochrome c1, along with other structural and survival-related
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proteins. 4-HNE also led to a decrease in oxygen consumption by decreasing the activity of
mitochondrial respiratory chain complex proteins. All these modifications of proteins by
4-HNE affected the cardiomyocyte energy generation process, leading to the development
of right ventricle failure [67].
Table 1. Major studies identifying the role of 4-HNE in different mitochondrial functions.
Cell or Tissue

Mitochondria Affected

Adducted Proteins, Mitochondria

References

Myocardial tissue

Calcium accumulation inside
mitochondria

VDAC and MCU

Santin, 2020 [66]

Myocardial tissue

Decrease in mitochondrial
respiratory chain complex I
and II activity

SDH

Lashin, 2006 [68]

Liver tissue

HMG-CoA synthase
inactivation

HMG-CoA synthase

Patel, 2007 [69]

RV myocardial tissue

Decreased oxidative
phosphorylation

NADH dehydrogenase [ubiquinone]
iron–sulfur protein 2, elongation
factor Tu, dihydrolipoyl
dehydrogenase, ES1 protein homolog,
fumarate hydratase, creatine kinase
S-type, cytochrome b–c1 complex
subunit 1, aconitate hydratase,
NADH dehydrogenase [ubiquinone]
1 alpha subcomplex subunit 10,
cytochrome c1, heme protein,
stress-70 protein, superoxide
dismutase

Hwang, 2020 [67]

Murine MII-stage oocyte

Loss of mitochondrial
membrane potential

SDHA

Lord, 2015 [70]

Cardiac tissue

Inactivates the oxidoreductase
activity of AIFm2

AIFm2

Miriyala, 2017 [7]

Cardiac tissue

Decreased oxygen
consumption rate

NADH ATP synthase subunit,
dihydrolipoyl dehydrogenase,
succinate dehydrogenase
[ubiquinone] flavoprotein subunit,
trifunctional enzyme subunit α,
creatine kinase S-type, cytoplasmic
isoform of fumarate hydratase,
succinyl-CoA:3-ketoacid–coenzyme A
transferase 1

Zhao, 2014 [71]

Myocardial tissue

Decreased oxygen
consumption rate, decreased
complex I and complex V
activity

NDUFS2, SDHA, ATP5B, and DLD

Sharma, 2020 [72]

It has been reported that 4-HNE activates the translocation of the mitochondrial
apoptosis-inducing factor (AIFM2) and facilitates apoptosis in the heart tissue of mice
and humans. It has also been found that xenobiotics such as doxorubicin significantly
enhance HNE levels, enabling an increase in the levels of AIFM2. HNE adduction of AIFM2
inactivates the NADH oxidoreductase activity of AIFM2 and facilitates its translocation
from the mitochondria. The main target of HNE adduction that triggers the functional
switch is HIS 174 on AIFm2. Recently, we demonstrated that a deficiency in SOD2 in the
conditional-specific cardiac knockout mouse increases ROS, leading to subsequent overproduction of 4-HNE inside mitochondria [72]. Cardiomyocyte-specific SOD2 knockout
mice (SOD2∆ ) had shorter life spans and died due to complications of dilated cardiomyopathy. Mechanistically, proteins in the mitochondrial respiratory chain complex and TCA
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cycle (NDUFS2, SDHA, ATP5B, and DLD) were the target of 4-HNE adduction in SOD2∆
hearts [72]. Consistent with the results from previous studies, which demonstrated that
the respiratory complex proteins NDUFS2 and SDHA are targets of 4-HNE [66,71], we
found that both proteins were also modified by 4-HNE in our SOD2∆ mice with dilated
cardiomyopathy [72]. Deficiency in SOD2 caused an increase in 4-HNE and a reduction
in the activity of the mitochondrial complex. Isolated, adult cardiac mitochondria and
neonatal cardiomyocytes [73] from SOD2∆ mice displayed reduced O2 consumption, particularly during basal conditions and after the addition of FCCP (H+ ionophore/uncoupler),
compared to wild-type hearts [72]. This demonstrated the effect of 4-HNE on mitochondrial stress signaling and heart failure and its role in the side effects of various xenobiotic
drugs [7]. Therefore, 4-HNE adversely affects various aspects of mitochondrial function,
such as oxidative phosphorylation, TCA cycle, calcium homeostasis, mitochondrial fission,
and fusion.
It has been established that diabetes is a risk factor for cardiovascular diseases [74,75].
Several studies have shown that oxidative stress is associated with diabetic hearts [76,77].
The characteristics of damaged mitochondria were seen in an animal model of a diabetic
heart, where a decrease in respiratory complex I and V activities was seen with an increase
in lipid droplets and swelling in mitochondria [78]. Diabetic hearts in the mouse exhibited
increased 4-HNE-adducted protein in the mitochondria. In the heart, 4-HNE particularly
modified mitochondrial respiratory chain protein succinate dehydrogenase (SDH), and
adduction occurred in the FAD-containing subunit of SDH. Mitochondria also showed
decreased activity in mitochondrial respiratory chain complex I and complex II activity [68].
Chronic ethanol consumption leads to oxidative stress either by causing ROS generation or decreasing antioxidant concentrations [79]. Ethanol consumption leads to excessive
production of mitochondrial ROS, leading to the opening of mitochondrial transition pores
and apoptosis [80]. In addition, chronic ethanol consumption causes the accumulation of
4-HNE inside the mitochondria of liver tissue and adducts with mitochondrial HMG-CoA
synthase, leading to its inactivation [69]. Chronic ethanol consumption in the rat has been
shown to cause an increase in 4-HNE and its adduction with several mitochondrial proteins, including mitofilin, dimethylglycine dehydrogenase, choline dehydrogenase, electron
transfer flavoprotein α, cytochrome c1, enoyl CoA hydratase, and cytochrome c, and these
protein adductions may contribute to ethanol-mediated mitochondrial dysfunction [81].
It has been reported that oxidative stress leads to the deterioration of aging oocytes. A
study on aged oocytes revealed an accumulation of 4-HNE due to increased cytosolic ROS
production [82]. Exposure to 4-HNE revealed that 4-HNE causes a decrease in mitochondrial membrane potential and eventual apoptosis of the metaphase II (MII)-stage oocyte.
Furthermore, they identified that the accumulation of 4-HNE leads to adduction to the
mitochondrial electron transport chain protein SDHA and possibly leads to collapse in the
electron transport chain [70].
5. Signaling and Cytotoxic Functions of 4-HNE
4-HNE has been established as a signaling molecule, although it is still considered
to be a toxic end product of lipid peroxidation. Earlier studies obscured the importance
of 4-HNE and how it reacts with the proteins, DNA, and lipids generating the signaling
pathway. The various signaling pathways induced by the involvement of 4-HNE include
apoptosis, stress response, cell cycle, activation of multiple kinases, gene expression, and
the inhibition or activation of critical enzymes [83–86].
5.1. Role of 4-HNE in Nrf2 Signaling
Nrf2 (nuclear factor-E2-related factor 2) is a transcription factor that activates the
transcription of a gene through ARE under oxidative stress conditions [87]. Under the
homeostatic condition, Nrf2 is subjected to ubiquitination and degradation by its cytosolic
inhibitor Keap-1 (Kelch-like ECH-associated protein 1) [88]. When cells are under oxidative
stress, oxidation of cysteine residue on Keap-1 causes its conformation change, which
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5.2. Role of 4-HNE in NFkB Signaling
Depending on the concentration, 4-HNE can be beneficial or detrimental to cells.
Many studies in the literature suggest that a 4-HNE concentration below 2 µM leads to cell
survival and proliferation. However, a concentration above 10 µM is detrimental to the cell,
leading to genotoxicity and cell death [91]. 4-HNE at micro-molecular concentrations leads
to the upregulation of nuclear factor kappa B (NF-κB), thereby regulating the expression
of kinases, such as protein kinase C (PKC) and mitogen-activated protein kinase (MAPK),
involved in cellular proliferation and differentiation. On the other hand, increased concentrations of 4-HNE inhibit NF-κB expression [91]. At lower concentrations, 4-HNE binds
with IKK and Ik-B, leading to expression of pro-inflammatory gene expression in human
fibroblast cells [92] (Figure 2). The study also suggested that 4-HNE regulates apoptosis signaling via the activation of JNK and c-Jun/AP-1 protein [93]. A preponderance of evidence
shows that 4-HNE triggers signals that modulate focal adhesion and adherent junction
proteins, which induce endothelial barrier dysfunction. As a result of oxidative stress, the
overproduction of 4-HNE and oxidized phospholipid (Ox-PL) occurs, contributing to the
pathophysiology of various diseases by modulating signaling pathways that regulate proand anti-inflammatory responses and barrier regulation [94]. 4-HNE affects the signaling
path and endothelial barrier dysfunction by modulating the activities of proteins/enzymes
by Michael adduct formation, enhancing the level of protein tyrosine phosphorylation of
the target proteins and reorganizing cytoskeletal, focal adhesion, and adherent junction
proteins [95]. A study carried out investigating vascular endothelial growth factor (VEGF)
in retinal pigment epithelial (RPE) cells showed that a low concentration of 4-HNE (0.1 µM)
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leads to increased secretion of VEGF, while its expression is blocked when the 4-HNE
concentration is greater than 5 µM. This effect of 4-HNE is regulated by GSTA4-4 [96].
Furthermore, 4-HNE was found to cause instability in atherosclerotic plaques by enhancing
the release of cytokines, such as IL-8, IL-1β, and TNF-α, thereby causing the upregulation
of matrix metalloproteinase-9 (MMP-9) via the TLR4/NF-κB B-dependent pathway [97].
6. Role of 4-HNE in Aging
It has been found that the HNE concentration in either free or adduct form increases
with aging [92]. 4-HNE also contributes as a signaling molecule in aging. HNE is involved
in aging-related signaling pathways through multiple entry points, such as NF-κB, AKT,
Nrf2, and mTOR. HNE can control the mTOR signaling network via modulating AKT
signaling or through the liver kinase B1 (LKB1) -AMPK-mTORC1 pathway. HNE (40 µM)
can conjugate with LKB1, thereby inhibiting AMPK activity and leading to the activation of
mTOR/p70S6K–RPS6 signaling (mTORC1) in isolated cardiomyocytes, HEK293T cells, and
rat ventricular cardiomyocytes [41,98–100]. Furthermore, mTORC1 phosphorylation modulates mitochondria function and autophagy [101–103]. Direct evidence of HNE–AMPK1
adducts is yet to be demonstrated, even though HNE inhibits AMPK activity [41,98,99,104].
In addition to these entry points, 4-HNE triggers EGFR related to growth factors and
PDGFR [105]. It has been shown that 4-HNE causes skin fibroblast senescence triggered by
UV-A exposure. This effect of 4-HNE is contributed by modifying vimentin filaments in
cultured skin fibroblasts [106].
7. Role of 4-HNE in Stroke
Stroke, one of the major causes of mortality worldwide, still lacks proper markers and
interventions for its management; however, oxidative stress markers are being considered
for this role [107,108]. 4-HNE, which is produced in response to oxidative insult in the
brain following stroke [107], is a major product formed by lipid peroxidation and has been
shown to be elevated in stroke patients following acute cerebral ischemia [109]. Lee et al.
observed significantly increased levels of plasma 4-HNE in rat models post middle cerebral
artery occlusion (MCAO). In addition, 4-HNE was found to be responsible for increased
infarct size and oxidative stress. Amplified plasma 4-HNE levels were discovered in a study
conducted on patients with post-ischemic stroke [110]. Elevated 4-HNE plasma levels were
observed for at least six months following the onset of stroke, and an eight-year follow-up
study revealed a relationship between higher initial levels of 4-HNE and the subsequent
development of stroke in human subjects [42,111]. It is well known that the cerebral
microvascular endothelial cells are essential for the formation of the blood–brain barrier,
which is disrupted during ischemic stroke. The genotoxic effect of 4-HNE on these cells,
when studied by Karlhuber et al., showed chromosomal aberrations at low concentrations
of 4-HNE, whereas higher concentrations showed cytotoxicity with a reduction in mitosis
of these cells and increased cell death [112,113].
Aldehyde dehydrogenase 2 family member (ALDH2) is a known mitochondrial enzyme that metabolizes 4-HNE, reducing its toxic effects. In prior studies, it was observed
that stroke-prone, spontaneously hypertensive rats (SHR-SP) were deficient in ALDH2,
leading to decreased neuroprotection [42]. A study by Li et al. showed reduced levels of
4-HNE following the administration of Alda-1, an ALDH2 agonist, in a rat MCAO model.
The increased ALDH2 activity decreased the infarct size and reduced brain edema with
an ultimate increase in a neurological deficit. Additionally, they observed a reduction
in AQP4 protein expression in the peri-infarct area with ALDH2 activity and reduced
edema following an ischemic stroke but increased levels of 4-HNE after MCAO-elevated
phosphorylation of ERK1/2 and p38 [114]. PKCε was also shown to regulate ALDH2 in
upstream protection against stroke, as ALDH2 knockdown rats demonstrated a loss in
neuroprotective effects, but the overexpression of PKCε increased ALDH2 by 44% and decreased infarct by 33% [42]. Together, these data provide evidence supporting the idea that
4-HNE and its regulating molecule ALDH2 can serve as potential biomarkers for stroke.
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8. Role of 4-HNE in Reproductive Physiology
A recent study suggested that maternally aged oocytes are subjected to oxidative stress
burden, leading to increased accumulation of 4-HNE [82,115]. Accumulation of 4-HNE is
prominent in oocyte and granulosa cells. 4-HNE decreases the quality of oocytes by causing chromosomal misalignment, meiotic spindle abnormality, microtubule spindle asters
formation, and deformities in the microtubule-organizing center (MTOC). The potential
target for 4-HNE adduction in the oocyte was found to be α-, β-, and γ-tubulins, leading to
increased aneuploidy rates [82]. It has been shown that one of the major causes of defective
sperm is oxidative stress. An increase in ROS within spermatozoa leads to the generation
of 4-HNE [116]. A study performed on human spermatozoa showed that treatment with an
electrophilic aldehyde such as 4-HNE leads to a dose- and time-dependent decrease in the
motility of sperm. 4-HNE treatment also leads to an increase in mitochondrial ROS, DNA
damage, and apoptosis of human spermatozoa. The potential target for 4-HNE adduction
in the mitochondria is SDHA, a subunit of mitochondrial respiratory chain complex II,
leading to decreased activity [117].
9. Role of Alcohol in 4-HNE-Induced Carcinogenesis
Ethanol and oxidative stress have a xenotoxic effect during carcinogenesis. Ethanolinduced esophageal carcinogenesis occurs via activation of cytochrome P450 2E1 (CYP2E1)
and adduct formation with DNA. It has been observed that CYPE1 is highly expressed in patients with esophageal squamous cell carcinoma compared to patients without tumors [118].
In a more recent study, Milloning et al. showed that alcohol increases CYPE1-mediated ROS
production in the mucosa of esophageal cancer patients. Furthermore, ROS production subsequently increases the lipid peroxidation products HNE and MDA, which react with DNA
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Warnakulasuriya and colleagues showed, for the first time, that immunoreactive CYP2E1
expression is markedly increased in the oral mucosa of squamous cell carcinoma and leukoplakia patients who have a history of chronic alcohol consumption, and that this
CYP2E1 expression is closely correlated with acetaldehyde, MDA, and HNE adduct formation in oral keratinocytes [120] (Figure 3).
10. Potential Therapeutics Targeting 4-HNE
Growing evidence suggests that mitochondrial aldehyde dehydrogenase detoxifies
ROS-mediated aldehyde adducts. Alda-1, the small molecule activator of aldehyde dehy-
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It has been reported that chronic alcohol consumption increases the accumulation of
protein adducts with acetaldehyde, MDA, and 4-HNE in the tissues exposed to alcohol.
Warnakulasuriya and colleagues showed, for the first time, that immunoreactive CYP2E1
expression is markedly increased in the oral mucosa of squamous cell carcinoma and leukoplakia patients who have a history of chronic alcohol consumption, and that this CYP2E1
expression is closely correlated with acetaldehyde, MDA, and HNE adduct formation in
oral keratinocytes [120] (Figure 3).
10. Potential Therapeutics Targeting 4-HNE
Growing evidence suggests that mitochondrial aldehyde dehydrogenase detoxifies
ROS-mediated aldehyde adducts. Alda-1, the small molecule activator of aldehyde dehydrogenase, has been shown to be beneficial in various pathological conditions such as
hypertension [121], stroke [42], chronic heart failure [122], hepatic ischemia/reperfusion
injury [45], lung ischemia/reperfusion injury [123], and myocardial ischemia/reperfusion
injury [124]. N-acetylcysteine (NAC), a thiol reducing agent, possesses antioxidant properties due to a free thiol group [125]. The use of NAC has been shown to be protective against the detrimental effect of 4-HNE, causing protein adduction and depletion
of antioxidants [84,126]. The study showed that superoxide dismutase (SOD) mimetic is
beneficial in attenuating ROS-induced toxicity in various pathological diseases. As mitochondria are the major site for ROS production, agents targeting the antioxidant defense
system, such as superoxide dismutase 2 (MnSOD), can serve as powerful therapeutics.
Miriyala et al. demonstrated the potential role of the following MnSOD mimetics to alleviate doxorubicin-induced cardiac injury: MnTnHex-2-PyP5+ , MnTnBuOE-2-PyP5+ (MnP),
and MnTE-2-PyP5+ [7]. The administration of an exogenous SOD mimetic has the potential
to restore the homeostatic balance between oxidants and antioxidants. Specifically, several
mitochondrial-based antioxidants are popular in treating heart disease since mitochondria
are the major site of ROS production [127]. Different types of metal complexes containing
Mn with MnSOD-like activity have been developed over the years. Among them, MnP
shows promise as a potential pre-treatment for ROS-induced damage due to its lipophilicity
and less toxic profile when compared with other manganese (Mn)-based mimetics [128].
MnP is currently undergoing early-phase clinical trials in reducing oxidative damage
caused by radiation and chemotherapy. Furthermore, MnP has been tested and shown
to mitigate oxidative damage in several cell types [129,130]. MnP reduces ROS levels
either directly or indirectly through inhibition of NF-κB or activation of the Nrf2 signaling pathways [130,131] These mimetics not only restore the oxidant:antioxidant balance,
but they also serve as ROS scavengers to help alleviate the ROS-induced injury seen in
many pathological diseases. In addition to targeting MnSOD, inhibition of arachidonate
15-lipoxygenase (ALOX15) has been shown to decrease HNE production in human spermatozoa [132]. 4-HNE-induced ROS have been implicated in male infertility because they
reduce the function and motility of the sperm [133]. ALOX15 is a lipoxygenase involved in
4-HNE production. Bromfield et al. demonstrated the attenuation of ROS-induced HNE
production by pharmacological inhibition with PD146176, a selective ALOX15 inhibitor.
Inhibition of ALOX15 decreased mitochondrial ROS as well as cellular ROS, which reduced
lipid peroxidation and subsequent 4-HNE formation [6]. Overproduction of ROS in spermatozoa has been linked to infertility; therefore, ALOX15 may serve as another potential
therapeutic target in attenuating 4-HNE-induced cell damage. Targeting the enzymes
responsible for 4-HNE production, ROS scavengers, and restoring the oxidant:antioxidant
balance all serve as potential mechanisms for future therapeutics.
11. Conclusions
Mitochondrial cellular bioenergetics and metabolism play a vital role in maintaining
cellular homeostasis. 4-HNE formed from the peroxidation of lipids can modify cellular
function by covalent adduction with proteins. 4-HNE can be derived from cardiolipin
peroxidation by cross-chain peroxyl radical addition and decomposition. 4-HNE can
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adduct with several mitochondria proteins involved in metabolism, calcium homeostasis,
apoptosis, mitochondrial fission, and fusion. The increment of 4-HNE has been linked to
the pathogenesis of various diseases, including cardiovascular diseases. ALDH2 activation
has been shown to be beneficial in several pathological conditions by causing a decreased
level of 4-HNE. Even though most of the evidence cited is from in vitro cell culture studies,
new studies are emerging with conditional-specific knockout mouse models for major
antioxidant enzymes such as SOD2 in the mitochondria [87] to further validate the effect of
HNE in an organelle-specific manner.
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